Is the amyloid hypothesis the right path to find a treatment for Alzheimer's disease?

There is both risk and reward in focusing Alzheimer's disease research on inhibiting amyloid production, according to a new article. The article reviews the significant body of research proposing that the accumulation of beta amyloid in the brain is the Alzheimer's disease trigger that must be inhibited.